Managing Atopic Diseases across Age Group Dr. Kamal Kant Kohli27 Feb 2023 11:30 AM ISTAtopy is a genetic tendency to produce high IgE antibodies in response to common allergens, which increases the risk of developing atopic illnesses...
Decoding the role of Azelastine and Fluticasone Furoate Fixed Dose Combination Spray in Management of Allergic Rhinitis Dr. Kamal Kant Kohli4 Jan 2023 11:15 AM ISTAllergic rhinitis (AR) is a widespread disease that affects approximately 400 million people globally, and its incidence has risen over time, posing a...
Unfolding Allergic Rhinitis and Asthma Link: Reviewing Role of Intranasal Spray in Pediatric Patients Dr. Kamal Kant Kohli24 Dec 2022 10:45 AM ISTWith a prevalence of up to 50% across nations, allergic rhinitis (AR) is among the most prevalent immunologically mediated allergic diseases...
Union Health Ministry notifies 300 drug brands under Schedule H2, Details Farhat Nasim21 Nov 2022 5:38 PM ISTNew Delhi: The Union Health Ministry has mandated Barcode or Quick Response (QR) Code on the label of top 300 brands of drugs including Dolo, Allegra,...
Respiratory Allergies in India and Clinical Review of Montelukast Fexofenadine Combination in its Management Dr. Kamal Kant Kohli24 Sept 2022 11:57 AM ISTAllergic respiratory diseases (ARDs) are caused by the production of IgE antibodies to airborne allergens, causing various clinical manifestations in...
Management of Allergic Rhinitis during COVID-19 Pandemic Dr. Kamal Kant Kohli27 Jun 2022 12:00 PM ISTThe COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) has challenged the healthcare systems and altered the...
Air pollution and allergic rhinitis: Understanding the invisible, yet the inevitable connection Dr. Kamal Kant Kohli19 May 2022 12:54 PM ISTThe spiking frequency of allergic respiratory illness over the last several decades, and the increasing rate of air pollution owing to urbanization,...
Analyzing the efficacy and safety of leukotriene receptor antagonists in the management of allergic rhinitis Dr. Kamal Kant Kohli29 April 2022 12:00 PM ISTAllergic Rhinitis (AR) is an inflammatory illness of the upper respiratory tract, with sneezing, itching, nasal congestion, and rhinorrhea as the most...
Review: Patient preferences for Intranasal Corticosteroids on account of Sensory Attributes Dr. Kamal Kant Kohli11 April 2022 9:00 AM ISTIntranasal corticosteroids are the pillar treatment for allergic rhinitis, a broad disease that affects over 500 million people around the world...
Review: Intranasal corticosteroids in Allergic rhinitis Dr. Kamal Kant Kohli28 Feb 2022 11:54 AM ISTAllergic Rhinitis is one of the most common persistent conditions for which clinical intervention is sought and is a significant cause of widespread...
Morepen Labs anti-allergy drug Fexofinadine gets USFDA approval Ruchika Sharma4 Dec 2021 12:36 PM ISTNew Delhi: Morepen Laboratories Limited has received U. S. Food and drug Administration (USFDA) approval for its anti-allergy drug Fexofinadine...
